UNITEDHEALTH GROUP INC

UnitedHealth’s new S‑8 filings show how the insurer ties executive pay to profit and quality, reinforcing its low debt, high margin and growing telehealth strategy.

UnitedHealth Group files $1.2 B in new deferred‑compensation plans, boosting talent incentives while strengthening liquidity—see the 10‑Q recap for details.

Discover why UnitedHealth Group is deemed an undervalued stock by BetterInvesting: steady earnings, strategic value‑based moves, and growth in AI‑driven care. Click to learn more.

UnitedHealth’s objection to OKXICE’s tokenized equity keeps its market cap stable, safeguards capital for value‑based care, and supports tech investments that improve patient access.

UnitedHealth Group’s latest earnings beat expectations, with steady revenue growth and robust cash flow, making it a top pick for investors seeking stability in healthcare.

UnitedHealth’s Q3 2026 earnings reveal a 7.3% EPS lift, $18.4 bn revenue growth driven by PBM fees and a stronger commercial insurance portfolio.

UnitedHealth Group Q3 2026 earnings beat forecasts, boosting its Medicare Advantage focus and guiding strong 2027 outlook—see how the insurer’s strategy drives profits.

Explore how UnitedHealth Group’s Q3 earnings and upside guidance reshape the healthcare insurance sector, market sentiment, and investment opportunities.

UnitedHealth’s Q3 earnings preview: how margin focus, enrollment growth, and cost‑control could set the pace for Medicare Advantage and the broader healthcare market.

UnitedHealth Group’s Q4 outlook shows robust revenue growth, AI‑driven cost cuts, and strong value‑based gains—highlighting how data and tech drive profitability in healthcare.